EMPOWERPHARM

What this means for you

Not registered yet, but its 26 Oct 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

97092446

Mark type

Stylized text

Filed

26 Oct 2021

Attorney of record

Nicole K. McLaughlin

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations containing synthetic cannabidiol (CBD) for the treatment of various diseases, conditions and disorders; Pharmaceutical preparations containing synthetic cannabidiol (CBD) for the treatment of anxiety, stress, pain and insomnia; Pharmaceutical preparations containing synthetic cannabidiol (CBD) for the treatment of anxiety; Natural health products, namely, glucosamine, turmeric supplements, dietary supplements to aid digestion, melatonin, sleep support supplements, fish oils, probiotics in tablet, capsule, gummy vitamin and liquid form; vitamin supplements; mineral supplements; vitamin and mineral food supplements; vitamin and mineral dietary supplements; vitamin preparations; mineral preparations; multivitamins; prenatal vitamins; calcium supplements; nutritional supplements for general health and well-being, namely, magnesium in tablets, capsules, gummies, and liquids; dietary supplements for promoting weight loss; over the counter medications for treating aches, pains, headaches, arthritis pain, sprains, and for treatment of minor joint injuries and muscle soreness, nonsteroidal anti-inflammatory drugs (NSAIDs), ibuprofen, naproxen sodium, acetaminophen, cold, sore throat and cough medications, guaifenesin, liquid cough medicines with dextromethorphan, decongestant nasal sprays, pseudoephedrine, phenylephrine, allergy medications, antihistamine pills and liquids, diphenhydramine, chlorpheniramine, brompheniramine, loratadine, fexofenadine, cetirizine, stomach upset medications, namely, probiotic preparations for medical purposes to help maintain a natural balance of flora in the digestive system, antidiarrhea medicines, loperamide, bismuth, nausea treatment preparations, pharmaceutical preparations for the treatment of vomiting and motion sickness, dimenhydrinate; cannabidiol (CBD) oil for medical purposes; cannabidiol (CBD) for medical purposes; cannabidiol (CBD) for medical purposes in the form of suppositories, sublingual doses that dissolve in the mouth, creams, ointments, and doses for absorption in the mucous membranes; tablets, capsules, gummies, suppositories, skin patches, sublingual doses, extended release tablets and liquids for therapeutic purposes containing cannabidiol (CBD); herbal supplements containing cannabidiol (CBD); Liquid nutritional supplement containing cannabidiol (CBD) for treating, reducing or improving symptoms of various conditions, namely, pain, anxiety, depression, cancer, acne, skin conditions, neuroprotection, cardiovascular health, arthritis, inflammation, autoimmune conditions, epileptic seizures, nausea, appetite, inflammatory bowel disease, and insomnia; tetrahydrocannabinol (THC) for medical purposes; tetrahydrocannabinol (THC) for medical purposes in sublingual doses and doses for absorption in the mucous membranes; tablets, capsules, gummies, suppositories, skin patches, sublingual doses, extended release tablets and liquid for therapeutic purposes containing tetrahydrocannabinol (THC) and containing a combination of tetrahydrocannabinol (THC) together with cannabidiol (CBD)

Owner

• EmpowerPharm Inc., Burlington, Ontario, CA

Prosecution history

• 02 May 2023 — ASSIGNED TO EXAMINER
• 20 Dec 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
• 20 Dec 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 20 Dec 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
• 09 Nov 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 29 Oct 2021 — NEW APPLICATION ENTERED